Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Wednesday, July 02, 2014 10:25:50 AM
bullish short squeeze
$MYGN
DD Notes ~ http://www.ddnotesmaker.com/MYGN
##### recent news/filings ~ source: finance.yahoo.com
Thu, 26 Jun 2014 22:41:00 GMT ~ Novo, Other Medicals Display Healthy Action
read full: http://news.investors.com/062614-706421-novo-other-medicals-display-healthy-action.htm?ven=yahoocp&src=aurlled&ven=yahoo
*********************************************************
Tue, 10 Jun 2014 20:05:00 GMT ~ Crescendo Bioscience to Present Multiple Studies at 2014 EULAR Meeting
[GlobeNewswire] - Vectra(R) DA Identified Patients in SWEFOT Clinical Study at Higher Risk of Joint Damage
read full: http://finance.yahoo.com/news/crescendo-bioscience-present-multiple-studies-200500660.html
*********************************************************
Mon, 09 Jun 2014 22:53:00 GMT ~ A Few Medical Research Stocks Break Out, Others Basing
read full: http://news.investors.com/060914-704005-medical-research-stocks-leading.htm?ven=yahoocp&src=aurlled&ven=yahoo
*********************************************************
Mon, 09 Jun 2014 21:10:39 GMT ~ MYRIAD GENETICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
read full: http://biz.yahoo.com/e/140609/mygn8-k.html
*********************************************************
Mon, 09 Jun 2014 20:05:00 GMT ~ Myriad Announces Retirement of James Evans, Chief Financial Officer
[GlobeNewswire] - SALT LAKE CITY -- Myriad Genetics, Inc. announced today that James Evans, chief financial officer of Myriad, has notified the Company of his intent to retire in order to attend to family health issues. ...
read full: http://finance.yahoo.com/news/myriad-announces-retirement-james-evans-200500975.html
*********************************************************
##### chart ~ source: stockcharts.com
##### chart ~ source: eoddata.com
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/MYGN/company-info
Ticker: $MYGN
OTC Market Place: Not Available
CIK code: 0000899923
Company name: Myriad Genetics, Inc.
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000899923&owner=exclude&count=40
Latest filings: http://www.otcmarkets.com/stock/MYGN/filings
Latest financials: http://www.otcmarkets.com/stock/MYGN/financials
Latest news: http://www.otcmarkets.com/stock/MYGN/news - http://finance.yahoo.com/q/h?s=MYGN+Headlines
Major holdings: http://data.cnbc.com/quotes/MYGN/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=MYGN+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/MYGN.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=MYGN
RegSho: http://www.regsho.com/tools/symbol_stats.php?sym=MYGN&search=search
DTCC: http://search2.dtcc.com/?q=Myriad+Genetics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&q=Myriad+Genetics%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results?term=Myriad+Genetics%2C+Inc.&x=0&y=0
Short Sales: http://www.otcmarkets.com/stock/MYGN/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/MYGN/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/MYGN/research
Historical Prices: http://finance.yahoo.com/q/hp?s=MYGN+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=MYGN+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=MYGN+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=MYGN+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=MYGN+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=MYGN+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=MYGN
Balance Sheet: http://finance.yahoo.com/q/bs?s=MYGN
Cash Flow: http://finance.yahoo.com/q/cf?s=MYGN+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/MYGN
Bloomberg: http://www.bloomberg.com/quote/MYGN:US
Morningstar: http://quotes.morningstar.com/stock/s?t=MYGN
Bussinessweek: http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=MYGN
Barchart: http://www.barchart.com/quotes/stocks/MYGN
OTC Short Report: http://otcshortreport.com/index.php?index=MYGN
Investopedia: http://www.investopedia.com/markets/stocks/MYGN/?wa=0
http://www.pennystocktweets.com/stocks/profile/MYGN
##### last known share structure ~ source: otcmarkets.com
Market Value: $2,912,141,985 a/o
Shares Outstanding: 74,823,792 a/o May 02, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.01
##### business description ~ source: otcmarkets.com
DD Notes ~ http://www.ddnotesmaker.com/MYGN
Recent MYGN News
- Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health Monitor • GlobeNewswire Inc. • 04/17/2024 12:00:00 PM
- New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen • GlobeNewswire Inc. • 04/16/2024 01:15:00 PM
- Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing • GlobeNewswire Inc. • 04/09/2024 12:00:00 PM
- Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date • GlobeNewswire Inc. • 03/22/2024 01:40:00 AM
- Myriad Genetics Announces Patent Granted for SneakPeek® Snap Device • GlobeNewswire Inc. • 03/20/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:18:02 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/28/2024 01:31:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:05:47 PM
- Myriad Genetics Reports Strong Fourth Quarter and Full-Year 2023 Financial Results; Fourth Quarter Revenue of $197 Million and Full-Year Revenue of $753 Million Each Grew 11% Year-Over-Year; Delivered GAAP EPS of $(0.36) and Adjusted EPS of $0.04 in the Fo • GlobeNewswire Inc. • 02/27/2024 09:05:00 PM
- Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Monitoring Clinical Trial, SCRUM-MONSTAR-SCREEN-3 • GlobeNewswire Inc. • 02/27/2024 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:12:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:09:56 PM
- Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 • GlobeNewswire Inc. • 02/21/2024 09:05:00 PM
- Myriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor of Women’s Health • GlobeNewswire Inc. • 02/15/2024 09:05:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:47:48 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:24:26 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/08/2024 03:14:32 PM
- Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics • GlobeNewswire Inc. • 02/01/2024 02:25:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:15:23 PM
- Myriad Genetics Names George Daneker Jr., MD, as President and Chief Clinical Officer of Oncology • GlobeNewswire Inc. • 01/30/2024 10:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 09:27:38 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 09:21:59 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/23/2024 09:31:19 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/22/2024 07:03:13 PM
- Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics • GlobeNewswire Inc. • 01/18/2024 11:10:00 PM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM